How do Exponent's multidisciplinary assessments help you understand the market for medical device manufacturing and innovation?
When making strategic investment and development decisions regarding medical devices, surgical implants, and biopharmaceutical products, Exponent delivers fast, thorough assessments and support. We help clients identify unmet needs in the marketplace, understand clinical indications, evaluate patient-reported and physician-reported outcome measures, assist in materials selection, and conduct engineering analysis and technical reviews. We also support clients in meeting FDA and regulatory requirements, developing global market strategies, tackling issues of pricing and medical insurance reimbursements, and we provide guidance on medical device testing and testing protocols.
Research and analysis.
We help companies and venture capitalists alike analyze the competitive environment and refine a company's strategies for venture capital financing, research and development, and product marketing.
Strategic insights based on sound science.
Our science-based analyses provide a foundation for both investor funding and, later, for payor reimbursement. We provide advice to investment banks and investment funds in a wide range of areas, including mergers and affiliations, corporate acquisitions, technology licensing, reimbursement planning, portfolio analysis, patent prosecution, litigation, and due diligence.
The MTAP program provides analysis of the following:
Unmet needs determination
Patient-reported and clinician-reported outcome (ClinRos) measures
Technology (engineering analysis and review)
Target condition epidemiology (size of market U.S. and worldwide)
FDA and other regulatory hurdles
Pricing and reimbursement issues
Complications and/or failure modes (liability)
Testing and testing protocols
For 50+ years, we’ve thrived on solving unstructured problems that require bespoke solutions. Some of our services include:
• Clinical and regulatory support (e.g., FDA liaison)
• Strategic direction for companies acquiring new technology or developing new devices and therapeutics
• Appraisal of markets for product introduction
• Design and conduct clinical trials and post-market surveillance programs
• Business risk assessment
• Analyses of cost-effectiveness relative to the standard of care
The Real Problem with Counterfeit Medical Products
Our global and comprehensive expertise across industries gives us a deep understanding of current challenges, best industry practices, and the implications of emerging technologies.
Group Vice President and Principal Engineer
Senior Managing Engineer
Our Capabilities Are Unparalleled
With expertise in over 90 disciplines and hundreds of capabilities, tools, and methodologies — we get to the root of even the most complex challenges and give you the objective answers you need.
Multidisciplinary Expertise to Support the Life Sciences Industry
Support for next-gen medical devices, wearable technologies, and pharmaceutical products.
Emerging Infectious Diseases
Scientific research, strategy, and tactics to support strategic planning related to numerous aspects of emerging infectious diseases.
Healthcare & Life Sciences Value & Outcomes Assessment
Strategic guidance for medical product value and access, including drugs, vaccines, and medical devices.
Multidisciplinary Expertise for Pharmaceutical Testing & Modeling
Evaluate pharmaceuticals with pharmacodynamic modeling, clinical epidemiology, and pharmacoepidemiology studies.
Occupational & Environmental Epidemiology
Advanced epidemiological research and evidence-based insights from leading epidemiologists and biostatisticians.
Occupational and environmental health risk assessment and mitigation strategies to help protect employee health and wellness.
Chemical Toxicology & Health Risk Assessments
Exposure assessments, toxicity evaluations, and support for issues of toxicology and mechanistic biology.